BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

SunTech Medical, Inc. and AtCor Medical Holdings Limited Announce Strategic Alliance to Collaborate on New Blood Pressure and Cardiovascular Assessment and Management Solutions


1/23/2012 8:58:19 AM

ITASCA, IL and MORRISVILLE, NC--(Marketwire - January 23, 2012) - Two leaders in blood pressure management, SunTech Medical Inc., a leader in noninvasive blood pressure products and technologies, and AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor® system, which noninvasively measures central blood pressures and arterial stiffness, announced today that the companies have formed a strategic alliance aimed at improving blood pressure measurement and overall cardiovascular health assessment and management.

The alliance will bring together SunTech Medical's expertise in motion-tolerant and other application specific blood pressure measurement technologies and AtCor Medical's market-leading technology for the noninvasive measurement of central aortic blood pressure. Together, the companies will develop and deliver new blood pressure monitoring products and solutions to benefit patient diagnosis, hypertension management and the global research community.

"We are extremely pleased to form this alliance with AtCor Medical. Their SphygmoCor systems have become the gold standard for measuring central aortic blood pressure and arterial stiffness," said Dayn McBee, CEO at SunTech Medical. "We are very excited about what the future holds in bringing our two companies and technologies together and cooperating on integrated offerings."

Duncan Ross, AtCor Medical CEO added, "We regard this alliance as an important step towards developing improved and more comprehensive capabilities to assess cardiovascular disease progression and therapeutic efficacy. SunTech Medical has a strong history of delivering blood pressure monitoring solutions to the market and we're delighted to bring our capabilities together."

The announcement of this important strategic alliance builds on the agreement announced in July 2011, whereby AtCor Medical is the worldwide exclusive distributor of the SunTech Oscar 2™ twenty-four-hour blood pressure monitor to the pharmaceutical clinical trials market.

About SunTech Medical
For over twenty years, SunTech Medical has been the preeminent supplier of clinical grade blood pressure monitoring products and technologies. Over 75 companies trust SunTech Medical's OEM non-invasive blood pressure solutions for their patient monitoring needs. SunTech produces the leading cardiac stress test blood pressure monitor and is the world's foremost manufacturer of ambulatory blood pressure monitoring (ABPM) products. SunTech Medical also offers solutions for in-office BP monitoring as well as a complete line of blood pressure cuffs designed for general and specific applications. For more information, visit www.suntechmed.com.

About AtCor Medical
AtCor Medical develops and markets products for the early detection of cardiovascular risk and management of cardiovascular disease. Its technology allows researchers and clinicians to measure central blood pressure non-invasively. The company's SphygmoCor® system visibly identifies the effects of reflected blood pressure in the central aortic pressure wave, effects which cannot be detected with standard blood pressure monitoring. More than 2,700 SphygmoCor® systems are currently in use worldwide at major medical institutions, research institutions and in various clinical trials with leading pharmaceutical companies. The company's technology has been featured in over 600 peer-reviewed studies published in leading medical journals. AtCor has operations in Australia, the United States, and Europe. For further information, please visit our web site at www.atcormedical.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->